Skip to content

13F-HR filed by Lion Point Capital, LP

Lion Point Capital, LP filed this 13F-HR for the quarter ended 2023-06-30, filed 2023-08-14, with 30 holding rows worth $221,299,532.

Accession
0001013594-23-000689
Filed
2023-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2023

A holdings report, 30 entries on the cover page, a total value of $221,299,532 stated on the cover page (in dollars after the unit check, H1), rows summing to $221,299,532 with VALUE read as dollars as filed, 13F file number 028-17316. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
SEMTECH CORP COM816850101Stock2,500,000$63,650,000dollars as filedcall
SEMTECH CORP COM816850101Stock2,452,855$62,449,688dollars as filed
MARINUS PHARMACEUTICALS INC56854Q200COM NEW2,257,521$24,516,678dollars as filed
SPY78462F103SHS50,000$22,164,000dollars as filedput
CHORD ENERGY CORPORATION674215207COM NEW102,403$15,749,581dollars as filed
ARDELYX INC039697107COM1,526,667$5,175,401dollars as filed
BURGERFI INTERNATIONAL INC12122L101COM2,745,938$4,311,123dollars as filed
SERES THERAPEUTICS INC81750R102COM691,803$3,313,736dollars as filed
DURECT CORP266605500COM601,664$2,978,237dollars as filed
BATTALION OIL CORP07134L107COM380,891$2,174,888dollars as filed
KINIKSA PHARMACEUTICALS LTDG5269C101COM CL A130,691$1,840,129dollars as filed
BLUEBIRD BIO INC09609G100COM531,256$1,747,832dollars as filed
Milestone Pharmaceuticals Inc59935V107COM450,207$1,283,090dollars as filed
ACLARIS THERAPEUTICS INC COM00461U105Stock109,898$1,139,642dollars as filed
2SEVENTY BIO INC COMMON STOCK901384107Stock111,667$1,130,070dollars as filed
CYMABAY THERAPEUTICS INC23257D103COM99,425$1,088,704dollars as filed
INSMED INC COM PAR $.01457669307Stock50,335$1,062,069dollars as filed
FENNEC PHARMACEUTICALS INC31447P100COMMON STOCK110,000$971,300dollars as filed
HORIZON THERAPEUTICS PLCG46188101SHS7,400$761,090dollars as filed
SYNDAX PHARMACEUTICALS INC87164F105COM34,500$722,085dollars as filed
MIRUM PHARMACEUTICALS INC604749101COM27,000$698,490dollars as filed
WHITEHAWK THERAPEUTICS INC00032Q104CMN82,423$563,773dollars as filed
Mersana Therapeutics Inc59045L106Common Stock146,000$480,340dollars as filedcall
ORIGIN MATERIALS INC68622D106COM100,000$426,000dollars as filed
HARPOON THERAPEUTICS INC41358P106COM456,514$324,125dollars as filed
BURGERFI INTERNATIONAL INC12122L119*W EXP 12/16/2022,083,438$265,638dollars as filedcall
LUMOS PHARMA INC55028X109COM78,351$258,558dollars as filed
Microsoft Corp594918104COM100$34,054dollars as filed
Alphabet Inc. Reg. Shares C02079K107COM100$12,097dollars as filed
PDC ENERGY INC69327R101COM100$7,114dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001013594-23-000689this filing2023-08-14acceptance time not in the bulk data set